Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric molecule for the treatment of th2-like cytokine mediated disorders

Chimeric molecule for the treatment of th2-like cytokine mediated disorders

US Patent 7541040 · Granted Jun 2, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interleukin-4 receptor-binding fusion proteins and uses thereof2025
Method of predicting progression of idiopathic pulmonary fibrosis and monitoring2022
Interleukin-4 receptor-binding fusion proteins and uses thereof2022
Interleukin-4 receptor-binding fusion proteins and uses thereof2021
Use of cysteamine and derivatives thereof to suppress tumor metastases2021
Synergistic combination of IL-4, interferon gamma, and interferon alpha in treat2020
Antibody targeting stem cell factor2019
Antibody targeting stem cell factor2019
Stem cell factor inhibitor2017
Stem cell factor inhibitor2017
Targeted cargo protein combination therapy2017
Stem cell factor inhibitor2016